Biotech CEO who relied on multiple aliases sentenced to 7 years in prison for Theranos-like $28 million fraud involving a fake finger-prick Covid test

The CEO of a California biotech company, Decision Diagnostics, claimed to have a finger-prick test that could detect Covid-19 and used multiple fake identities to pump up the company’s stock price, authorities said. The CEO, Keith Berman, was sentenced on Friday to seven years in prison for the…#decisiondiagnostics #keithberman #departmentofjustice #nicoleargentieri #justicedepartments #criminaldivision #westlakevillage #matthewsteinmann #investorshangout #decisiondiagnostic
Source: Reuters: Health - Category: Consumer Health News Source Type: news